🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Infants aged 9 months will be randomized to receive a meningococcal vaccine...
Status
Completed
Location
Centre pour le Developpement des Vaccins du Mali
Start Date
2022-03-24
Trial ID
NCT05093829
Treatments Being Tested
Primary Objective: To assess maternal, obstetrical, pregnancy, and neonata...
Status
Recruiting
Location
Pennsylvania Locations
Start Date
2021-03-05
Trial ID
NCT04843111
Treatments Being Tested
Primary Objective: To demonstrate: * the non-inferiority of the seroprote...
Status
Completed
Location
Investigational Site Number 2080001
Start Date
2019-09-12
Trial ID
NCT03890367
The purpose of the study was to evaluate the immunogenicity and describe th...
Status
Completed
Location
Investigational Site
Start Date
2017-02-17
Trial ID
NCT03077438
The purpose of this study is to evaluate the immunogenicity and safety of M...
Status
Unknown
Location
Liujiang Center for Disease Control and Prevention
Start Date
2021-12-18
Trial ID
NCT05252715
The purpose of this study was to compare the immunogenicity and describe th...
Status
Completed
Location
Birmingham Pediatric Associates Site Number : 8400026
Start Date
2018-04-25
Trial ID
NCT03537508
The primary objective of this study is to evaluate the safety of adjuvanted...
Status
Completed
Location
Center for Vaccine Development
Start Date
2016-08-01
Trial ID
NCT02810340
Treatments Being Tested
Primary Objective: 1. To describe the vaccine seroprotection (antibody tit...
Status
Completed
Location
Investigational Site Number :4840001
Start Date
2018-10-17
Trial ID
NCT03630705
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of t...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00355121
The aim of the study was to demonstrate non-inferiority of immunogenicity a...
Status
Completed
Location
Multiple Locations
Start Date
2016-07-15
Trial ID
NCT02842866